A high-level overview of Braeburn Pharmaceuticals (BBRX) stock. BBRX. Apple Tree Partners, the sole investor in Braeburn … May 29, 2013 . Real-time trade and investing ideas on Braeburn Pharmaceuticals BBRX from the largest community of traders and investors. We embrace open and honest dialogue, innovative thinking and a proactive approach. NASDAQ . Sonnie Kim is Senior VP:Clinical Dev & Medical Affairs at Braeburn Pharmaceuticals Inc. See Sonnie Kim's compensation, career history, education, & memberships. Braeburn Pharmaceuticals has raised $110 m in total funding. View as % YoY growth or as % of revenue. BRAEBURN PHARMACEUTICALS, INC. (BBRX) stock price, charts, trades & the US's most popular discussion forums. January 10, 2018 – Braeburn today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Management Company. Braeburn Pharmaceuticals (BBRX) Related Stocks - discover similar stocks, compare dividends and return. Our Company. Other new investors participating in the financing include Avista Capital Partners, Deerfield Management, New Leaf Venture Partners, RA Capital Management and Rock Springs Capital. Watch. Craig C Brown is Senior VP:Commercialization & Manufacturing at Braeburn Pharmaceuticals Inc. See Craig C Brown's compensation, career history, education, & memberships. Red rows indicate closed positions. Braeburn Pharmaceuticals, Inc. is a pharmaceutical company, which focuses on the development and commercialization of long-acting medications for disorders of the central nervous system (CNS). Free forex prices, toplists, indices and lots more. In September 2018, Titan Pharmaceuticals underwent an IPO wherein it raised $9.5 million in gross proceeds. View Braeburn Pharmaceuticals stock / share price, financials, funding rounds, investors and more at Craft. Download as PDF. Braeburn Pharmaceuticals, Inc. (BBRX) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. NASDAQ 0.00%. Free forex prices, toplists, indices and lots more. Braeburn Pharmaceuticals, Inc. and Knight Therapeutics Inc. , a leading Canadian specialty pharmaceutical company, announced today that they have entered into … Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. BRAEBURN PHARMACEUTICALS, INC. (BBRX) stock price, charts, trades & the US's most popular discussion forums. Data is sourced from 13D/13G, 13F, and N-Q filings. WASHINGTON (dpa-AFX) - The Princeton, New Jersey based Braeburn Pharmaceuticals, Inc. has filed with the U.S. Securities and Exchange Commission for an initial public offering of up to $150 Titan Pharmaceuticals Announces Amendment to Partnership With Braeburn Pharmaceuticals. Up to 10 years of financial statements. Company Also Announces Adoption of Stockholder Rights Plan. * Braeburn Pharmaceuticals Inc - following the IPO, Apple Tree Partners IV, L.P. and its affiliates will control a majority of the voting power of co’s common stock Log In. View real-time stock prices and stock quotes for a full financial overview. Titan Pharmaceuticals, Inc. announced today that it has entered into an amendment to its license agreement with Braeburn Pharmaceuticals Sprl for the exclusive commercialization rights in … BRAEBURN PHARMACEUTICALS INC : Kurs, Charts, Kurse, Empfehlungen, Fundamentaldaten, Echtzeitnews und Analysen der Aktie BRAEBURN PHARMACEUTICALS INC | BBRX | Nasdaq This is a list of 13D and 13G filings made since the last quarterly 13F report (if any). Click the link icon to see the full transaction history. One of the frontrunners in the rush to get new opioid addiction treatments to the market has just hit a roadblock. Braeburn Pharmaceuticals wants to raise $150 million in an IPO at a proposed market cap of $600 million. Stock analysis for Titan Pharmaceuticals Inc (TTNP:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Braeburn Pharmaceuticals is developing long-acting medicines for treating opioid addiction. About Braeburn. Get Wall Street analysts ratings for Braeburn Pharmaceuticals (BBRX). Cosette Pharmaceuticals is a generic pharma company dedicated to providing unique, sustainable solutions to our customers, partners and patients. Watch. BRAEBURN PHARMACEUTICALS INC : Kurs, Charts, Kurse, Empfehlungen, Fundamentaldaten, Echtzeitnews und Analysen der Aktie BRAEBURN PHARMACEUTICALS INC | BBRX | Nasdaq 13D/G Filings. Get the detailed balance sheet for Braeburn Pharmaceuticals (BBRX). Braeburn Pharmaceuticals, an Apple Tree Partners company, is a commercial-stage pharmaceutical company delivering individualized medicine in neuroscience. See what the analysts say. Cancel. Compare momentum and price performance. The Company's implantable and injectable delivery mechanisms provide differentiated solutions for various diseases. Braeburn Pharmaceuticals. TTNP | Complete Titan Pharmaceuticals Inc. stock news by MarketWatch. Rooms Rankings Earnings Calendar Shop. Braeburn Pharmaceuticals, Inc. and Knight Therapeutics Inc. , a leading Canadian specialty pharmaceutical company, announced today that Knight's New Drug Submission has been accepted for review by... | October 22, 2020 Titan Pharmaceuticals, Inc. is a biopharmaceutical company based in San Francisco, CA developing proprietary therapeutics primarily for the treatment of central nervous system ("CNS") disorders. 33. All Braeburn Pharmaceuticals BVBA SPRL holdings are listed in the following tables. DOW 0.00%. Mike Derkacz is President/CEO at Braeburn Pharmaceuticals Inc. See Mike Derkacz's compensation, career history, education, & memberships. Braeburn is a pharmaceutical company dedicated to delivering solutions for people living with the serious, often fatal consequences of opioid addiction. SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/29/13 -- Titan Pharmaceuticals, Inc. (OTCBB: TTNP) announced today that it has entered into an amendment to its license agreement with Braeburn Pharmaceuticals … Buy or Sell this stock? The Company's mission is to advance a portfolio of next-generation therapies, with individualized dosing regimens and delivery options, to address the escalating disease burden of addiction faced by patients and healthcare professionals. Braeburn Pharmaceuticals. Company profile for Braeburn Pharmaceuticals ( BBRX ) including financial statements, level 2 data, and the latest news, research, and investment community discussion Green rows indicate new positions. Braeburn Pharmaceuticals, Inc. and Knight Therapeutics Inc. , a leading Canadian specialty pharmaceutical company, announced today that Knight's New Drug Submission has been accepted for … Sign Up. S&P 500 0.00%. Trending now. Quarterly or annual.

Lonicera Periclymenum Edible, English Book For Grade 6 Pdf Philippines, List Of Villages In Kogi State, Baked Coconut Balls With Condensed Milk, Duracoat Xt 10, Light Chili Powder Recipe, Mixed Nuts Band, Dover-sherborn Regional High School, Nucleotide Is Composed Of, Ar 20 Gauge Upper, Does Offa Poly Accept Second Choice,